Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth

Circulation

Volumn 102, Issue 4, 2000, Pages 374-379

  McGill Jr , Henry C ^a,b   McMahan, C Alex ^a   Zieske, Arthur W ^c   Tracy, Richard E ^c   Malcom, Gray T ^c   Herderick, Edward E ^d   Strong, Jack P ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Coronary disease; Risk factors; Youth

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; AUTOPSY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DYSLIPOPROTEINEMIA; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0343789044     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.4.374     Document Type: Article

References (40)

1. National Cholesterol Education Program. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
2. Hunink MGM, Goldman L, Tosteson ANA, et al. The recent decline in mortality from coronary heart disease, 1980-1990: the effect of secular trends in risk factors and treatment. JAMA. 1997;277:535-542.
3. Kuller LH. Future in lipid and lipoprotein research: from preventing clinical disease to preventing elevated risk factors. Atherosclerosis. 1994;108(suppl):S143-S156.
4. Davidoff F. Evangelists and snails redux: the case of cholesterol screening. Ann Intern Med. 1996;124:513-514.
5. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions: a review of autopsy studies. Arteriosclerosis. 1983;3:187-198.
6. Wissler RW. USA multicenter study of the pathobiology of atherosclerosis in youth. Ann N Y Acad Sci. 1991;623:26-39.
7. McGill HC Jr, McMahan CA, Malcom GT, et al, for the PDAY Research Group. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscler Thromb Vasc Biol. 1997;17:95-106.
8. McGill HC Jr, McMahan CA, Tracy RE, et al, for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Arterioscler Thromb Vasc Biol. 1998; 18:1108-1118.
9. McGill HC Jr, McMahan CA, Malcom GT, et al, Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Arterioscler Thromb Vasc Biol. 1995;15:431-440.
10. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res. 1966;6:1-17.
11. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 1997;17:1859-1867.
12. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462-2478.
13. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995; 15:1512-1531.
14. Montenegro MR, Eggen DA. Topography of atherosclerosis in the coronary arteries. Lab Imest. 1968;18:586-593.
15. Stary HC. Macrophages, macrophage foam cells, and eccentric intimai thickening in the coronary arteries of young children. Atherosclerosis. 1987; 64:91-108.
16. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375.
17. Stary HC, Blankenhorn DH, Chandler AB, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb. 1992;12:120-134.
18. Agresti A. Analysis of Ordinal Categorical Data. New York, NY: John Wiley & Sons; 1984.
19. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989.
20. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea: preliminary report. JAMA. 1953;152:1090-1093.
21. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis. 1989;9(suppl 1):I-19-I-32.
22. McGill HC Jr. Fatty streaks in the coronary arteries and aorta. Lab Invest. 1968;18:560-564.
23. Stehbens WE. The epidemiological relationship of hypercholesterolemia, hypertension, diabetes mellitus and obesity to coronary heart disease and atherogenesis. J Clin Epidemiol. 1990;43:733-741.
24. Loree HM, Tobias BJ, Gibson LJ, et al. Mechanical properties of model atherosclerotic lesion lipid pools. Arterioscler Thromb. 1994;14:230-234.
25. Kullo IJ, Edwards WD, Schwartz RS. Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med. 1998;129:1050-1060.
26. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
27. Falk E. Why do plaques rupture? Circulation. 1992;86(suppl III):III-30-III-42.
28. Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
29. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276-1282.
30. Burke AP, Farb A, Malcom GT, et al. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA. 1999;281:921-926.
31. Garber AM, Browner WS, Hulley SB. Clinical guideline, part 2: cholesterol screening in asymptomatic adults, revisited. Ann Intern Med. 1996;124:518-531.
32. Hulley SB, Newman TB, Grady D, et al. Should we be measuring blood cholesterol levels in young adults? JAMA. 1993;269:1416-1419.
33. American College of Physicians. Clinical guideline, part 1: guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med. 1996;124:515-517.
34. LaRosa JC, Hunninghake D, Bush D, et al. The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Circulation. 1990;81:1721-1733.
35. Kannel WB, Schatzkin A. Sudden death: lessons from subsets in population studies. J Am Coll Cardiol. 1985;5(suppl 6):141B-149B.
36. Traven ND, Kuller LH, Ives DG, et al. Coronary heart disease mortality and sudden death: trends and patterns in 35- to 44-year-old white males, 1970-1990. Am J Epidemiol. 1995;142:45-52.
37. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
38. Berenson GS, Srinivasan SR, Nicklas TA, et al. Cardiovascular risk factors in children and early prevention of heart disease. Clin Chem. 1988;34(suppl):B115-B122.
39. Lauer RM, Connor WE, Leaverton PE, et al. Coronary heart disease risk factors in school children: the Muscatine study. J Pediatr. 1975;86:697-706.
40. Van Horn L, Greenland P. Prevention of coronary artery disease is a pediatric problem. JAMA. 1997;278:1779-1780.